Literature DB >> 15661430

Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies.

Per T Hansson1, Anthony H Dickenson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15661430     DOI： 10.1016/j.pain.2004.10.007

Source DB:  PubMed          Journal:  Pain        ISSN： 0304-3959            Impact factor:   6.961


× No keyword cloud information.
  11 in total

Review 1.  Epidemiology of neuropathic pain and its impact on quality of life.

Authors:  Blair H Smith; Nicola Torrance
Journal:  Curr Pain Headache Rep       Date:  2012-06

2.  An optimal protocol to analyze the rat spinal cord proteome.

Authors:  F Gil-Dones; S Alonso-Orgaz; G Avila; T Martin-Rojas; V Moral-Darde; G Barroso; F Vivanco; J Scott-Taylor; M G Barderas
Journal:  Biomark Insights       Date:  2009-10-28

Review 3.  Measuring GABAergic inhibitory activity with TMS-EEG and its potential clinical application for chronic pain.

Authors:  Mera S Barr; Faranak Farzan; Karen D Davis; Paul B Fitzgerald; Zafiris J Daskalakis
Journal:  J Neuroimmune Pharmacol       Date:  2012-06-29       Impact factor: 4.147

Review 4.  Neuropathic pain: a practical guide for the clinician.

Authors:  Ian Gilron; C Peter N Watson; Catherine M Cahill; Dwight E Moulin
Journal:  CMAJ       Date:  2006-08-01       Impact factor: 8.262

Review 5.  Recommendations for the pharmacological management of neuropathic pain: an overview and literature update.

Authors:  Robert H Dworkin; Alec B O'Connor; Joseph Audette; Ralf Baron; Geoffrey K Gourlay; Maija L Haanpää; Joel L Kent; Elliot J Krane; Alyssa A Lebel; Robert M Levy; Sean C Mackey; John Mayer; Christine Miaskowski; Srinivasa N Raja; Andrew S C Rice; Kenneth E Schmader; Brett Stacey; Steven Stanos; Rolf-Detlef Treede; Dennis C Turk; Gary A Walco; Christopher D Wells
Journal:  Mayo Clin Proc       Date:  2010-03       Impact factor: 7.616

Review 6.  Challenges in the development of novel treatment strategies for neuropathic pain.

Authors:  Michael H Ossipov; Frank Porreca
Journal:  NeuroRx       Date:  2005-10

Review 7.  Pharmacological management of neuropathic pain following spinal cord injury.

Authors:  Cathrine Baastrup; Nanna B Finnerup
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

8.  Presynaptic inhibition of optogenetically identified VGluT3+ sensory fibres by opioids and baclofen.

Authors:  Silke D Honsek; Rebecca P Seal; Jürgen Sandkühler
Journal:  Pain       Date:  2015-02       Impact factor: 7.926

Review 9.  Evidence and consensus recommendations for the pharmacological management of pain in India.

Authors:  Gur Prasad Dureja; Rajagopalan N Iyer; Gautam Das; Jaishid Ahdal; Prashant Narang
Journal:  J Pain Res       Date:  2017-03-29       Impact factor: 3.133

10.  Changes in microRNA expression in the brachial plexus avulsion model of neuropathic pain.

Authors:  Yuzhou Liu; Le Wang; Jie Lao; Xin Zhao
Journal:  Int J Mol Med       Date:  2017-12-19       Impact factor: 4.101
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.